Securities code: Andon Health Co.Ltd(002432) securities abbreviation: Andon Health Co.Ltd(002432) Announcement No.: 2022039
Andon Health Co.Ltd(002432) about
Announcement on the completion of daily operation major contracts and orders of the company’s U.S. subsidiaries
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and bear joint and several liabilities for false records, misleading statements or major omissions in the announcement. 1、 Overview and main contents of contracts and orders
Andon Health Co.Ltd(002432) (hereinafter referred to as “the company”) subsidiary ihealth labs The order for ihealth covid-19 antigen home self-test OTC Kit (hereinafter referred to as ihealth Kit) received by Inc (hereinafter referred to as the “U.S. subsidiary”) from New York and Massachusetts takes effect on the date of receipt of the order (local time); Sales of ihealth kits signed with the New York State Department of health
The contract shall come into force by both parties on January 10, 2022 local time. The details are as follows:
On December 21, 2021 local time, the total amount of orders sent by the Department of health of New York state
USD 6531000000 (including freight) (hereinafter referred to as “New York state order”). In addition, the son of the United States
The company and the Department of health of New York state signed the sales contract (hereinafter referred to as “the contract”) on January 10, 2022 local time
(hereinafter referred to as “New York state contract”) to sell ihealth kit products to the New York State Department of health of the United States. The total contract price tax is USD 12000000000 (including freight). To sum up, the order and contract amount of the Department of health of the state of New York in the United States totaled US $18531000000 (including freight).
From December 3, 2021 to January 5, 2022, local time of the United States, Massachusetts was obtained
The Commonwealth of Massachusetts
And Executive Office of health and human services
The company’s U.S. subsidiary sells ihealth kits to the Executive Office of the Massachusetts federal and Department of health and human services, with a total contract price tax of US $14832740000 (including freight).
For details of the above matters, please refer to the securities times and China Securities Journal published on January 13, 2022
And cninfo (www.cn. Info. Com. CN.) Announcement on signing major daily operation contracts and obtaining orders by the company’s U.S. subsidiaries (Announcement No.: 2022009). 2、 Performance of contract and order
Recently, through the reconciliation between the two purchasing entities of contracts and orders in New York State, namely the Department of health of New York State and health research incorporated, a non-profit organization in New York State, it was found that the purchase of ihealth kit had not been completed. On April 22, 2022 local time, the US Department of health of the state of New York communicated the above situation with the US subsidiary of the company. Through consultation, the purchase amount of orders and contracts in the state of New York was adjusted to US $17522500000 (including freight), about RMB 113188341000 (calculated according to the central rate of US dollar to RMB exchange rate on April 22, 2022, US $1 = RMB 6.4596). Up to now, the company has completed the delivery obligations of the above orders and contracts in New York State, and received all the payment from the Department of health in New York state. The above orders and contracts have been fulfilled.
As of April 22, 2022 us time, the company has completed the delivery obligation of the above Massachusetts order and received the payment of USD 14933340000 (actual freight increase) paid by the Commonwealth of Massachusetts, about RMB 96463403064 (calculated according to the central rate of USD to RMB exchange rate on April 22, 2022 = RMB 6.4596). The above order has been fulfilled. 3、 Impact on the company
The performance of the above major contracts and orders will have a positive impact on the company’s operating revenue and operating profit in the corresponding accounting year. The company will recognize the current revenue in the corresponding accounting period according to the relevant accounting standards for revenue recognition. The specific financial data shall be subject to the audited financial report. 4、 Documents for future reference
Relevant certificates of receipt of the company’s U.S. subsidiaries. It is hereby announced
Andon Health Co.Ltd(002432) board of directors April 25, 2022
